GSK Secures FDA Priority Review for Jemperli as Hibsago Wins First Global Approval in Japan
GSK ©Adobe Stock Images GSK (LSE:GSK) has reached two significant regulatory milestones across its oncology and hepatology portfolios,…
GSK’s sBLA for Jemperli Gets FDA Priority Tag in Rectal Cancer
GSK plc GSK announced that the FDA has accepted for review its supplemental biologics license application (sBLA) seeking approval…
New launches, innovative portfolio set to drive gains for GSK Pharma stock | Markets News
In addition to a strong Q1 show, brokerages expect the company to post strong growth in…
GSK to seek FDA approval for Jemperli in high-profile cancer use
In what GSK says represents a potential way to transform treatment for patients with certain types of rectal…
GSK India aims to double revenue to ₹8K cr by FY30: MD Bhushan Akshikar | Industry News
Oncology currently makes a negligible contribution to GSK India’s revenue. How materially can it contribute over…
GSK (LSE:GSK) Wins FDA Nod For Jideytro As Bexsero And Jemperli Advance
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors…
GSK Eyes FDA Filing After Immunotherapy Succeeds in Key Rectal Cancer Study
GSK has results from a pivotal clinical trial showing rectal cancer patients treated with its drug avoided the…
GSK’s Jemperli Delivers Promising Interim Data in Rectal Cancer
GSK plc GSK has announced positive interim data from a mid-stage study evaluating its oncology drug, Jemperli (dostarlimab), in…
Surgery-Free Rectal Cancer Treatment Edges Closer as Dostarlimab Clears Registrational Trial
GSK announced Sunday that dostarlimab (Jemperli), its PD-1–blocking immunotherapy, met the primary endpoint of the AZUR-1 registrational Phase…
GSK reports Jemperli rectal cancer trial results
GSK reported positive interim results from the AZUR-1 Phase II trial of Jemperli in dMMR/MSI-H locally advanced rectal…
GSK’s Jemperli meets main goal in mid-stage rectal cancer trial
GSK said on Monday its cancer drug Jemperli met the primary goal of a mid-stage trial, with a…
GSK Reports Encouraging Phase II Results for Jemperli in Rectal Cancer Study (GSK)
GSK ©Adobe Stock Images GSK (LSE:GSK) has announced positive interim results from the Phase II AZUR-1 trial evaluating…